Forecast & Rating2 analysts currently cover Lisata Therapeutics, of which 0 give a positive rating. The average price target is $4.00, about 288.3% upside from the current price of $1.03. Coverage is limited, so the data is for reference only. Data as of Jul 27, 2026; this does not constitute investment advice.
Jul 27, 2026
Price forecast
$4.00288.35%
Forecast & RatingHold
2analysts
Strong buy0.00%
Buy0.00%
Hold100.00%
Sell0.00%
Strong sell0.00%
Strong buy
0
Buy
0
Hold
2
Sell
0
Strong sell
0
Target price forecast
Forecast baselineJul 26, 2026
Forecast met0.0%
Stock price$1.03
Average forecast price$13.0
Highest forecast price$15
Lowest forecast price$9
Average forecast price
$13.0
Highest forecast price
$15
Lowest forecast price
$9
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.